These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 36764322)

  • 1. Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy.
    Aloisi F; Giovannoni G; Salvetti M
    Lancet Neurol; 2023 Apr; 22(4):338-349. PubMed ID: 36764322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of Epstein-Barr virus in the etiology of multiple sclerosis: a current review.
    Ruprecht K
    Expert Rev Clin Immunol; 2020 Dec; 16(12):1143-1157. PubMed ID: 33152255
    [No Abstract]   [Full Text] [Related]  

  • 3. Preventing and curing multiple sclerosis by controlling Epstein-Barr virus infection.
    Pender MP
    Autoimmun Rev; 2009 Jun; 8(7):563-8. PubMed ID: 19254880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis.
    Meier UC; Cipian RC; Karimi A; Ramasamy R; Middeldorp JM
    Front Immunol; 2021; 12():757302. PubMed ID: 34790199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus as a leading cause of multiple sclerosis: mechanisms and implications.
    Bjornevik K; Münz C; Cohen JI; Ascherio A
    Nat Rev Neurol; 2023 Mar; 19(3):160-171. PubMed ID: 36759741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
    Farrell RA; Antony D; Wall GR; Clark DA; Fisniku L; Swanton J; Khaleeli Z; Schmierer K; Miller DH; Giovannoni G
    Neurology; 2009 Jul; 73(1):32-8. PubMed ID: 19458321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Epstein-Barr virus in multiple sclerosis: when and how?
    Giovannoni G
    Curr Opin Neurol; 2024 Jun; 37(3):228-236. PubMed ID: 38511407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain.
    Willis SN; Stadelmann C; Rodig SJ; Caron T; Gattenloehner S; Mallozzi SS; Roughan JE; Almendinger SE; Blewett MM; Brück W; Hafler DA; O'Connor KC
    Brain; 2009 Dec; 132(Pt 12):3318-28. PubMed ID: 19638446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.
    Serafini B; Rosicarelli B; Veroni C; Mazzola GA; Aloisi F
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31578295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis.
    Pender MP
    Neuroscientist; 2011 Aug; 17(4):351-67. PubMed ID: 21075971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus as a driver of multiple sclerosis.
    Sollid LM
    Sci Immunol; 2022 Apr; 7(70):eabo7799. PubMed ID: 35363541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered Immune Response to the Epstein-Barr Virus as a Prerequisite for Multiple Sclerosis.
    Läderach F; Münz C
    Cells; 2022 Sep; 11(17):. PubMed ID: 36078165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MINI-review of Epstein-Barr virus involvement in multiple sclerosis etiology and pathogenesis.
    Aloisi F; Cross AH
    J Neuroimmunol; 2022 Oct; 371():577935. PubMed ID: 35931008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for multiple sclerosis in the context of Epstein-Barr virus infection.
    Hedström AK
    Front Immunol; 2023; 14():1212676. PubMed ID: 37554326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EBV as the 'gluten of MS' hypothesis: Bypassing autoimmunity.
    Aloisi F; Veroni C; Serafini B
    Mult Scler Relat Disord; 2022 Oct; 66():104069. PubMed ID: 35908445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus and multiple sclerosis.
    Pohl D
    J Neurol Sci; 2009 Nov; 286(1-2):62-4. PubMed ID: 19361810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis.
    Vietzen H; Berger SM; Kühner LM; Furlano PL; Bsteh G; Berger T; Rommer P; Puchhammer-Stöckl E
    Cell; 2023 Dec; 186(26):5705-5718.e13. PubMed ID: 38091993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Infection by Epstein-Barr virus and multiple sclerosis].
    Alonso A; Egüés Olazábal N; Ayo Martín O
    Neurologia; 2006 Jun; 21(5):249-55. PubMed ID: 16788867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What do animal models tell us about the role of EBV in the pathogenesis of multiple sclerosis?
    Hassani A; Khan G
    Front Immunol; 2022; 13():1036155. PubMed ID: 36466898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus and multiple sclerosis.
    Soldan SS; Lieberman PM
    Nat Rev Microbiol; 2023 Jan; 21(1):51-64. PubMed ID: 35931816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.